BRAF and melanoma: A retrospective study analyzed 683 patients with advanced BRAF-mutated melanoma treated with first-line immunotherapy or targeted therapy; the authors evaluated brain metastasis-free survival, OS, incidence of brain metastases, and sequencing strategies.